ArticlePharmaceutical medicine2024

A Sponsor's Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan.

Kevin D Wolter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.